Immune Pharmaceuticals Inc (fka IMNPQ)

[Bigtrade PT]

Nasdaq First North is a division of Nasdaq Nordic and an alternative stock exchange for smaller companies in Europe.[1] The market place Nya Marknaden in Stockholm changed name to First North in June 2006[2] and the First North exchange expanded to the stock exchange on Iceland in January 2007 and Helsinki in April 2007.

First North is Nasdaq's European growth market, designed for small and growing companies. Using a less extensive rulebook than the main market, the First North market provides companies more room to focus on their business and development while still taking advantage of all the positive aspects of being a listed company. And unlike the regulated main market, every company on First North has a Certified Adviser to ensure that companies comply with all requirements and rules. Many large and established companies began their journey on First North, creating growth and gaining experience. Many of these companies went on to listing on the Nasdaq regulated main market.

The First North market runs parallel to the main market, where the shares are traded in a single trading system. This allows approximately 200 European trading members of Nasdaq to easily trade on the two markets. For investors, First North offers an opportunity to invest in companies that are in an interesting stage of their growth. In addition, First North is a diversified market where companies represent a variety of industries, operating both in the Nordics and globally.


https://en.wikipedia.org/wiki/Nasdaq_First_North